ZA201103170B - A triazolothiadiazole inhibitor of c-met protein kinase - Google Patents

A triazolothiadiazole inhibitor of c-met protein kinase

Info

Publication number
ZA201103170B
ZA201103170B ZA2011/03170A ZA201103170A ZA201103170B ZA 201103170 B ZA201103170 B ZA 201103170B ZA 2011/03170 A ZA2011/03170 A ZA 2011/03170A ZA 201103170 A ZA201103170 A ZA 201103170A ZA 201103170 B ZA201103170 B ZA 201103170B
Authority
ZA
South Africa
Prior art keywords
triazolothiadiazole
inhibitor
protein kinase
met protein
met
Prior art date
Application number
ZA2011/03170A
Other languages
English (en)
Inventor
David Lauffer
Pan Li
Dean Shannon
Jianglin Liang
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharma filed Critical Vertex Pharma
Publication of ZA201103170B publication Critical patent/ZA201103170B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433Thidiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA2011/03170A 2008-11-19 2011-04-29 A triazolothiadiazole inhibitor of c-met protein kinase ZA201103170B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11603308P 2008-11-19 2008-11-19
PCT/US2009/064909 WO2010059668A1 (en) 2008-11-19 2009-11-18 A triazolothiadiazole inhibitor of c-met protein kinase

Publications (1)

Publication Number Publication Date
ZA201103170B true ZA201103170B (en) 2012-08-29

Family

ID=42027848

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2011/03170A ZA201103170B (en) 2008-11-19 2011-04-29 A triazolothiadiazole inhibitor of c-met protein kinase

Country Status (18)

Country Link
US (3) US8217056B2 (OSRAM)
EP (1) EP2365977B1 (OSRAM)
JP (1) JP5596047B2 (OSRAM)
KR (1) KR20110094285A (OSRAM)
CN (1) CN102216309B (OSRAM)
AR (1) AR074379A1 (OSRAM)
AU (1) AU2009316756B2 (OSRAM)
BR (1) BRPI0921509A2 (OSRAM)
CA (1) CA2743000A1 (OSRAM)
CL (1) CL2011001152A1 (OSRAM)
ES (1) ES2393693T3 (OSRAM)
IL (1) IL212906A0 (OSRAM)
MX (1) MX2011005250A (OSRAM)
NZ (1) NZ592825A (OSRAM)
RU (1) RU2011124894A (OSRAM)
TW (1) TW201024309A (OSRAM)
WO (1) WO2010059668A1 (OSRAM)
ZA (1) ZA201103170B (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2166008A1 (en) * 2008-09-23 2010-03-24 Genkyo Tex Sa Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
EP2166010A1 (en) * 2008-09-23 2010-03-24 Genkyo Tex Sa Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
BRPI0921509A2 (pt) * 2008-11-19 2016-03-08 Vertex Pharma inibidor triazolotiadiazol de proteína quinase c-met
MX2011012522A (es) * 2009-05-28 2012-02-08 Vertex Pharma Inhibidores de pirazol sustituido de proteina cinasa c-met.
CN102448969A (zh) 2009-05-28 2012-05-09 沃泰克斯药物股份有限公司 C-met蛋白激酶抑制剂
SG176574A1 (en) * 2009-05-28 2012-01-30 Vertex Pharma Aminopyrazole triazolothiadiazole inhibitors of c-met protien kinase
CN109283279B (zh) * 2017-07-21 2019-11-01 南京正大天晴制药有限公司 通过高效液相色谱法分离测定雷替曲塞及其对映异构体的方法
CN109897054B (zh) * 2017-12-08 2021-12-10 中国药科大学 三唑并噻二唑类c-Met激酶抑制剂的制备方法及其用途
AU2020242287A1 (en) 2019-03-21 2021-09-02 INSERM (Institut National de la Santé et de la Recherche Médicale) A Dbait molecule in combination with kinase inhibitor for the treatment of cancer
KR20220098759A (ko) 2019-11-08 2022-07-12 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) 키나제 억제제에 대해 내성을 획득한 암의 치료 방법
WO2021148581A1 (en) 2020-01-22 2021-07-29 Onxeo Novel dbait molecule and its use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5144532B2 (ja) * 2005-11-30 2013-02-13 バーテックス ファーマシューティカルズ インコーポレイテッド c−Met阻害剤及び用法
CA2651979A1 (en) * 2006-05-30 2007-12-06 Pfizer Products Inc. Triazolopyridazine derivatives
WO2008144767A1 (en) * 2007-05-21 2008-11-27 Sgx Pharmaceuticals, Inc. Heterocyclic kinase modulators
BRPI0921509A2 (pt) * 2008-11-19 2016-03-08 Vertex Pharma inibidor triazolotiadiazol de proteína quinase c-met

Also Published As

Publication number Publication date
BRPI0921509A2 (pt) 2016-03-08
KR20110094285A (ko) 2011-08-23
JP2012509279A (ja) 2012-04-19
NZ592825A (en) 2013-01-25
EP2365977A1 (en) 2011-09-21
ES2393693T3 (es) 2012-12-27
CA2743000A1 (en) 2010-05-27
US20110207774A1 (en) 2011-08-25
WO2010059668A1 (en) 2010-05-27
IL212906A0 (en) 2011-07-31
MX2011005250A (es) 2011-07-29
US8217056B2 (en) 2012-07-10
JP5596047B2 (ja) 2014-09-24
RU2011124894A (ru) 2012-12-27
CN102216309A (zh) 2011-10-12
AR074379A1 (es) 2011-01-12
US20100234423A1 (en) 2010-09-16
EP2365977B1 (en) 2012-10-03
AU2009316756A1 (en) 2010-05-27
CN102216309B (zh) 2014-05-07
AU2009316756B2 (en) 2016-02-25
TW201024309A (en) 2010-07-01
US20110301195A1 (en) 2011-12-08
US8343998B2 (en) 2013-01-01
CL2011001152A1 (es) 2012-02-24

Similar Documents

Publication Publication Date Title
HUS1900014I1 (hu) Proteinkináz inhibitorok
ZA201103170B (en) A triazolothiadiazole inhibitor of c-met protein kinase
IL213464A0 (en) Kinase inhibitor compounds
ZA201004942B (en) Ptrrolopyrazine kinase inhibitors
PT2200436E (pt) Pirimidinilaminas substituídas como inibidoras da proteína quinase
IL206416A0 (en) Benzofuropyrimidinones as protein kinase inhibitors
IL210073A0 (en) Protein kinase inhibitors
ZA201008808B (en) Novel phenylpyrazinones as kinase inhibitors
PL2079727T3 (pl) Inhibitory kinazy
IL210069A0 (en) Protein kinase inhibitors
IL211693A0 (en) Imidazopyridazinecarbonitriles useful as kinase inhibitors
ZA200901073B (en) Kinase inhibitor
EP2336123A4 (en) HETEROCYCLIC COMPOUND AS INHIBITOR OF PROTEIN KINASE
ZA200808599B (en) 4-anilinoquinoline-3-carboxamides as CSF-1R kinase inhibitors
IL210573A0 (en) Compounds as kinase inhibitors
EP2166857A4 (en) KINASE INHIBITOR COMPOUNDS
GB0621607D0 (en) Inhibitors of c-Met
ZA201108655B (en) Aminopyrazole triazolothiadiazole inhibitors of c-met protein kinase
ZA200908943B (en) Pyrazolopyrimidinone kinase inhibitor
ZA200810573B (en) Substituted 3-cyanopyridines as protein kinase inhibitors
IL197981A0 (en) Kinase inhibitors
GB0807642D0 (en) IKK- serine-threonine protein kinase inhibitors
GB0621980D0 (en) Inhibitors of c-Met
GB0715470D0 (en) IKK- serine-threonine protein kinase inhibitors
TH0901002078A (th) ไพโรโลไพริดีนในฐานะตัวยับยั้งไคเนส